EASL Campus

A 66-year-old, male patient with a BMI of 33 kg/m² is referred to the Hepatology outpatient clinic by his GP due to elevated serum transaminases (ALT 60 U/L, AST 58 U/L). At the outpatient clinic the calculated FIB-4 score was 1.92 and HBsAg and anti HCV were negative. An abdominal ultrasound was compatible with liver steatosis. To further investigate the risk of underlying liver fibrosis, transient elastography was performed and a liver stiffness of 9 kPa was objectified. A subsequent liver biopsy revealed NAFLD with F2 fibrosis. A PNPLA3 p.I148M mutation analysis was positive.

Which follow-up strategy would you propose?

A. EASL CP Guidelines recommend at least yearly visits as per best clinical practice by hepatologists, but no surveillance for HCC in this case

B. EASL CP Guidelines recommend to initiate a 6-monthly HCC surveillance with an abdominal ultrasound

C. EASL CP Guidelines recommend to initiate a 6-monthly HCC surveillance with an abdominal ultrasound and plasma AFP levels

D. Surveillance for HCC and clinical monitoring are not recommended by EASL CP Guidelines in this case

Community Stream

Easl Community Feed My Feed

Test Your Guidelines Knowledge

Community Stream